Literature DB >> 7595877

Psychological morbidity in newly referred patients with cancer.

S Ford1, S Lewis, L Fallowfield.   

Abstract

Over the last 10 yr, research has shown that although the majority of patients are able to cope with the stresses of cancer, a substantial number have difficulties which require some form of psychological help. This study reports on the levels of psychological distress in a heterogeneous group of 117 newly referred out-patients with cancer over a 6-month period. Each patient reported their levels of distress by completing two self-administered questionnaires (the GHQ-30 and HADS) on three separate occasions. A descriptive examination of the socio-demographic characteristics of the sample was also carried out. At the first assessment 30% of the sample scored above the threshold for probable psychiatric disorder on the GHQ-30 and 26% on the HADS anxiety scale. At 6 months follow-up levels had fallen to 21% for the GHQ-30 and 10% for HADS anxiety. The numbers of probable cases of HADS depression was 7% at the first assessment and 5% at follow-up. Differences in levels of psychological morbidity according to age, sex, partner status and socioeconomic group were demonstrated. However, we were unable to make any firm conclusions as to whether these effects were independent of each other as a controlled multivariate analysis of the data set was not possible.

Entities:  

Mesh:

Year:  1995        PMID: 7595877     DOI: 10.1016/0022-3999(94)00103-c

Source DB:  PubMed          Journal:  J Psychosom Res        ISSN: 0022-3999            Impact factor:   3.006


  23 in total

1.  Reducing the unmet needs of patients with colorectal cancer: a feasibility study of The Pathfinder Volunteer Program.

Authors:  Michelle L Macvean; Victoria M White; Sarah Pratt; Suzanne Grogan; Robert Sanson-Fisher
Journal:  Support Care Cancer       Date:  2006-09-01       Impact factor: 3.603

2.  Screening for mental disorders in cancer, cardiovascular and musculoskeletal diseases. Comparison of HADS and GHQ-12.

Authors:  Martin Härter; Sonja Woll; Alexandra Wunsch; Jürgen Bengel; Katrin Reuter
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2006-01-01       Impact factor: 4.328

Review 3.  Psychological factors in postoperative adjustment to stoma surgery.

Authors:  C A White; J C Hunt
Journal:  Ann R Coll Surg Engl       Date:  1997-01       Impact factor: 1.891

4.  Rapid assessment of psychosocial well-being: are computers the way forward in a clinical setting?

Authors:  Allison Boyes; Sallie Newell; Afaf Girgis
Journal:  Qual Life Res       Date:  2002-02       Impact factor: 4.147

5.  Who Is at Risk for Psychological Distress in Genetic Testing Programs for Hereditary Cancer Disorders?

Authors:  F J Grosfeld; C J Lips; F A Beemer; H F Ten Kroode
Journal:  J Genet Couns       Date:  2000-06       Impact factor: 2.537

6.  Hypnotizability, posttraumatic stress, and depressive symptoms in metastatic breast cancer.

Authors:  Alex S Keuroghlian; Lisa D Butler; Eric Neri; David Spiegel
Journal:  Int J Clin Exp Hypn       Date:  2010-01

7.  Measuring supportive and unsupportive responses during cancer treatment: a factor analytic assessment of the partner responses to cancer inventory.

Authors:  S Manne; R Schnoll
Journal:  J Behav Med       Date:  2001-08

8.  Pre-morbid predictors of psychological adjustment to cancer.

Authors:  A V Ranchor; R Sanderman; A Steptoe; J Wardle; I Miedema; J Ormel
Journal:  Qual Life Res       Date:  2002-03       Impact factor: 4.147

9.  Randomised controlled trial of a shared care programme for newly referred cancer patients: bridging the gap between general practice and hospital.

Authors:  J D Nielsen; T Palshof; J Mainz; A B Jensen; F Olesen
Journal:  Qual Saf Health Care       Date:  2003-08

10.  Psychiatric morbidity among cancer patients and awareness of illness.

Authors:  Figen Culha Atesci; Bahar Baltalarli; Nalan Kalkan Oguzhanoglu; Filiz Karadag; Osman Ozdel; Nursel Karagoz
Journal:  Support Care Cancer       Date:  2004-01-28       Impact factor: 3.603

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.